Valuation (69%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -9.67 | 11.86 |
| PEG Ratio (TTM) | -0.10 | 1.25 |
| P/S Ratio (TTM) | 0.30 | 4.71 |
| P/B Ratio (TTM) | 0.48 | 3.38 |
| P/FCF Ratio (TTM) | 5.21 | 21.41 |
| Price to 5YR AVG Earnings Ratio | 9.43 | 30.10 |
| Price to 5YR AVG FCF Ratio | 16.28 | 17.44 |
Profitability (5%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -2.59% | 3.00% |
| ROE (TTM) | -4.89% | 9.11% |
| Net Profit Margin (TTM) | -3.15% | -15.16% |
| ROIC 5YR AVG | 7.14% | 7.27% |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 15.94% | 1,389.64% | 811.10% |
| Revenue | 3.94% | 341.24% | 206.56% |
| Net Income | 18.08% | 1,406.73% | 821.43% |
| Cash Flow | 188.37% | 121.16% | 69.43% |
Health (47%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.75 | 2.54 |
| Quick Ratio (TTM) | 0.83 | 1.92 |
| D/E Ratio (TTM) | 0.45 | -0.26 |
| Interest Coverage (TTM) | -4.66 | 14.05 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 2.92 | 4.92 |
| LTL to 5YR AVG FCF | 13.19 | 4.30 |
| Shares Outstanding Growth 5YR AVG | -7.44% | 29.64% |